Media CentreCareersInvestors EN Contact Us
About Us
Back
About Us
Kamaptive Technology
Kamaptive Partnerships
Kamaptive Devices
Healthcare Professionals
Back
Healthcare Professionals
Pioneer Clinical Educational Programme
NHS Supply Chain Case Study for SSD
Improving Patient Pathways with SSD
Clinical Resources & Information
Case Gallery
Medical Specialities
Educational Webinars
Patients
Back
Patients
Patient Case Stories
Products
Back
Products
Advanced Energy
Gastroenterology
Pulmonology
Urology
Resection
Ablation
Diagnostics
Therapeutics
Hygiene
Diagnostics
Therapeutics
Diagnostics
Therapeutics
Media CentreCareersInvestors EN Contact Us

Kamaptive Partnerships

Creo’s Kamaptive Licensing Programme sees the company partner with selected industry leaders in adjacent, growing markets. Kamaptive Technology combines adaptive bipolar radiofrequency and super high-frequency microwave energy to dynamically adapt to patient tissue during procedures such as resection, dissection, coagulation and ablation. Powering Creo's CROMA platform, it provides clinicians with increased flexibility, precision and controlled surgical solutions.

Kamaptive technology’s architecture allows multiple Creo development teams to design, test and build innovative devices independently, whilst functioning with the CROMA platform without complex software changes or menu options for users.

Kamaptive’s full spectrum adaptive technology allows for partnership opportunities in new and innovative fields from robotics to laparoscopy. Kamaptive Technology intuitively adapts to the specific tool in use, self provisioning and intelligently enhancing the settings of the CROMA platform for the purpose of the device being used.

Creo technology is being adapted for use with robotic-assisted surgical platforms

The Programme allows Creo to explore the potential of our technology - introducing it to markets where it does not currently exist, and where it would be resource-intensive to do so alone.

By working with industry leaders on the development, optimisation or customisation of technology in relation to their needs and that of their industry, the Kamaptive Licensing Programme means our technology has the potential to reach thousands more patients worldwide.

Current Kamaptive Partnerships

Intuitive Surgical 

  • Multi-year collaboration agreement with Intuitive - a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery.
  • Agreement will see optimisation of certain Creo products to be compatible with Intuitive’s state of the art robotic technology.
  • Agreement also provides a framework to allow joint clinical studies to be undertaken and includes a number of milestone payments to be made to Creo.

CMR Surgical

  • CMR’s next-generation surgical robot, Versius®, is a significant new entrant into the robotic surgery space, performing laparoscopic procedures worldwide across a range of specialties.
  • A non-exclusive Intellectual Property Licence and Royalty Agreement has been made to integrate certain aspects of Creo’s technology with Versius®.

Kamaptive Partnership News

News

Kamaptive Licence and Royalty Agreement with CMR Surgical

Read

News

Collaboration agreement with Intuitive

Read

News

First in-human milestone reached for MicroBlate™ Flex

Read

News

Kamaptive Technology Licensing & Partnership update

Read

Learn More

Interested in our Kamaptive Advanced Energy?

Kamaptive Energy Contact Us
Healthcare Professionals
Online CommunityPioneer ProgrammeCases GalleryImproving Patient PathwaysCase StudiesHealthcare Professionals
About Us
About UsKamaptive Advanced EnergyKamaptive PartnershipsMedia CentreCareersSustainability Policy
Products
All ProductsKamaptive DevicesGastroenterologyUrologyPulmonology
Other
InvestorsCookie PolicyTerms of UsePrivacy PolicyContact
© 2024 Creo Medical. All rights reserved

This information contained in this website is intended as general information to demonstrate Creo Medical’s product range for healthcare professionals only and not the general public. Not all products are cleared/approved for use in all territories, and accordingly the availability of products may vary depending on the territory and current regulatory requirements and/or medical practices in such territory. Please read our full disclaimer for further details.